Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 24, 2010, Pages 10961-10966

  Cella, Marina ^a   Otero, Karel ^a   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell activating factor belonging to the TNF family; IL 22; Mucosal immunity; Natural killer cell

Indexed keywords

B CELL ACTIVATING FACTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 7; LEUKEMIA INHIBITORY FACTOR;

ARTICLE; CELL CULTURE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

B-CELL ACTIVATING FACTOR; BASE SEQUENCE; CELL PROLIFERATION; CYTOKINES; DNA PRIMERS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKIN-7; INTERLEUKINS; KILLER CELLS, NATURAL; LEUKEMIA INHIBITORY FACTOR; LYMPHOCYTE SUBSETS; PALATINE TONSIL; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 77954627022     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1005641107     Document Type: Article

References (27)

1. Cella M, et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722-725.
2. Colonna M (2009) Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31:15-23.
3. Aujla SJ, Kolls JK (2009) IL-22: A critical mediator in mucosal host defense. J Mol Med 87:451-454.
4. Zenewicz LA, Flavell RA (2008) IL-22 and inflammation: Leukin' through a glass onion. Eur J Immunol 38:3265-3268.
5. Veldhoen M, et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106-109. (Pubitemid 351630329)
6. Freud AG, Caligiuri MA (2006) Human natural killer cell development. Immunol Rev 214:56-72. (Pubitemid 44707902)
7. Hughes T, et al. (2009) Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113:4008-4010.
8. Cupedo T, et al. (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10:66-74.
9. Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H (2010) Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med 207:281-290.
10. Satoh-Takayama N, et al. (2008) Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29: 958-970.
11. Sanos SL, et al. (2009) RORgammat and commensal microflora are required for the differentiation ofmucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10:83-91.
12. Luci C, et al. (2009) Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 10:75-82.
13. Satoh-Takayama N, et al. (2010) IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 207:273-280.
14. Yu XL, et al. (2008) Crystal structure of HAb18G/CD147: Implications for immunoglobulin superfamily homophilic adhesion. J Biol Chem 283:18056-18065.
15. Guezguez B, et al. (2007) Dual role of melanoma cell adhesionmolecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction inlymphocyteandisan endothelial adhesionreceptor. J Immunol179:6673-6685.
16. Knoop KA, et al. (2009) RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol 183:5738-5747.
17. Laurence A, et al. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371-381.
18. Chung Y, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576-587.
19. McGeachy MJ, et al. (2009) The interleukin 23 receptor is essential for the terminal differentiationof interleukin 17-producingeffector T helper cells in vivo. Nat Immunol 10:314-324.
20. Quinton LJ, et al. (2008) Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am J Respir Cell Mol Biol 38:699-706.
21. Mackay F, Schneider P (2009) Cracking the BAFF code. Nat Rev Immunol 9:491-502.
22. Müller G, Höpken UE, Lipp M (2003) The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 195:117-135. (Pubitemid 37153458)
23. Bending D, et al. (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119:565-572.
24. Lee YK, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107.
25. Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C (2009) Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39:216-224.
26. Bluestone JA, Mackay CR, O'Shea JJ, Stockinger B (2009) The functional plasticity of T cell subsets. Nat Rev Immunol 9:811-816.
27. Vivier E, Spits H, Cupedo T (2009) Interleukin-22-producing innate immune cells: New players in mucosal immunity and tissue repair? Nat Rev Immunol 9:229-234.